Bright Eye Hospital Group Co., Ltd. (SHE:301239)

China · Delayed Price · Currency is CNY

30.85

+0.19 (0.62%)

At close: Sep 16, 2026

Market Cap	4.56B -20.9%
Revenue (ttm)	2.94B +8.2%
Net Income	12.52M
EPS	0.08
Shares Out	148.86M
PE Ratio	364.59
Forward PE	n/a
Dividend	0.60 (1.78%)
Ex-Dividend Date	Sep 11, 2026

Volume	1,524,895
Open	30.74
Previous Close	30.66
Day's Range	30.15 - 31.06
52-Week Range	28.35 - 48.32
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About Bright Eye Hospital Group

Bright Eye Hospital Group Co., Ltd., together with its subsidiaries, operates ophthalmic medical institutions in China. The company offers ophthalmic diagnostic and treatment services, including refractive surgery, medical optometry and glasses fitting, cataract surgery, glaucoma treatment, strabismus and amblyopia, pediatric ophthalmology, fundus diseases treatment, oculoplastic surgery, lacrimal duct surgery, and corneal diseases treatment, as well as low vision and visual rehabilitation. It is also involved in medical, hospital, and investme... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 2005

Employees 5,018

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301239

Full Company Profile

Financial Performance

In 2025, Bright Eye Hospital Group's revenue was 2.80 billion, an increase of 4.44% compared to the previous year's 2.68 billion. Losses were -60.92 million, -40.19% less than in 2024.

Financial Statements